Preferred Label : Levosimendan;
UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;
CAS number : C6T4514L4E;
Is substance : O;
Origin ID : M0206268;
UMLS CUI : C0246904;
ATC code(s)
ATC code(s)
CISMeF manual mappings
Related record
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3326704/fr/levosimendan-kabi-levosimendan
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
levosimendan
drugs, generic
adult
emergency treatment
Decompensation
infusions, intravenous
heart decompensation
evaluation of the transparency committee
Levosimendan
---
https://www.has-sante.fr/jcms/p_3339976/fr/levosimendan-kalceks-levosimendan-insuffisance-cardiaque
2022
false
false
false
France
infusions, intravenous
evaluation of the transparency committee
Heart failure
heart failure
heart failure, nos
Levosimendan
---
https://www.has-sante.fr/jcms/p_3327271/fr/levosimendan-accord-levosimendan
2022
false
false
false
France
evaluation of the transparency committee
Levosimendan
---
https://pharmactuel.com/index.php/pharmactuel/article/view/1294
2019
false
false
false
Canada
drug incompatibility
infusions, intravenous
journal article
ketamine
intensive care
Levosimendan
critical care
dexmedetomidine
Simendan
---
http://www.has-sante.fr/portail/jcms/c_2629887/fr/zimino
2016
false
false
false
France
French
evaluation of the transparency committee
infusions, intravenous
treatment outcome
Levosimendan
Levosimendan
levosimendan
Product containing precisely levosimendan 2.5 milligram/1 milliliter conventional
release solution for injection (clinical drug)
heart decompensation
acute disease
adult
cardiotonic agents
cardiotonic agents
emergency treatment
risk management
heart failure
hydrazones
pyridazines
hydrazones
pyridazines
Simendan
Simendan
---
http://revmed.ch/RMS/2005/RMS-21/30464
2005
Switzerland
French
hydrazones
pyridazines
cardiotonic agents
pyridazines
cardiotonic agents
hydrazones
treatment outcome
heart failure, systolic
heart failure, systolic
infusions, intravenous
levosimendan
Levosimendan
Levosimendan
drug information
journal article
Simendan
Simendan
Simendan
---